CD5+ CLL B cells show similar gene expression patterns to the healthy CD5+ B-1a B cells [4], but differ significantly from these cells with regard to other surface markers, exhibiting features of either activation or anergy after antigenic interactions [5]. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.